Atopic Dermatitis Archives - JDDonline - Journal of Drugs in Dermatology

Feb 13

Journal of Drugs in Dermatology JDD Article About Dupilumab Treatment Improves Lichenification in Atopic Dermatitis in Different Age and Racial Groups. Image from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas. It is one of the images from a side by side comparison of full range skin tones of a hand with atopid dermatitis (AD).

Dupilumab Treatment Improves Lichenification in Atopic Dermatitis in Different Age and Racial Groups

By Nadia Marcus Atopic Dermatitis, Featured Articles, JDD Highlights, Latest News, The Latest

JDD Spotlight: Dupilumab Shows Rapid, Sustained Relief for Lichenification in AD A new pooled analysis from five clinical trials has revealed that dupilumab significantly improves lichenification in moderate to severe…

Nov 20

Love10

Dermatology Roundup: Medicare Fee Schedule to Cut Physician Pay; Telemedicine Tool Found Accurate in Melanoma Diagnosis

By Nadia Marcus Atopic Dermatitis, Dermatology Roundup, Global Health, JDD Highlights, JDD in the Media, Skin Cancer, The Latest

By Allison Sit The American Academy of Dermatology (AAD) is joining with other specialties in speaking out about cuts to the Medicare Physician Fee Schedule for 2025. The physician services…

Nov 08

Love0

A Review of the Vitiligo Literature to Standardize Expression of Disease Severity

By Nadia Marcus Atopic Dermatitis, Featured Articles, The Latest

JDD Article Highlights Vitiligo research is often inconsistent when it comes to measuring disease severity, making it challenging to compare treatment outcomes. The IDEOM Vitiligo Workgroup has begun efforts to…

Oct 24

Love11

Efficacy and Tolerance of a Polymeric Surfactant Technology-Based Cleanser for Clinically Diagnosed Sensitive Skin

By Matt Breeman Atopic Dermatitis, JDD Highlights, Rosacea, Skin Barrier Function, The Latest, Video Pearls

Cleansing is a significant daily hygiene step used by many to fight against infections and keep the skin healthy. However, cleansing also presents new challenges in the face of skin…

Oct 18

Love10

Journal of Drugs in Dermatology JDD video exclusive titled Breaking New Ground in Atopic Dermatitis Treatment: Dr. Linda Stein Gold Discusses the “Level Up” Study

Breaking New Ground in Atopic Dermatitis Treatment: Dr. Linda Stein Gold Discusses the “Level Up” Study

By Matt Breeman Atopic Dermatitis, The Latest, Video Pearls

JDD Video Exclusive At the recent Revolutionizing Atopic Dermatitis (RAD) conference, Dr. Linda Stein Gold, Director of Dermatology Clinical Research and Division Head of Dermatology at Henry Ford Health,…

Oct 17

Love10

Dermatology Roundup: Semaglutide for HS, Acne Laser Receives FDA Clearance

By Matt Breeman Atopic Dermatitis, Dermatology Roundup, JDD Highlights, JDD in the Media, The Latest

By Allison Sit Semaglutide – a glucagon-like peptide (GLP)-1RA – improved outcomes for obese patients with hidradenitis suppurativa (HS), according to a study presented at EADV Congress 2024. The study…

Sep 24

Love11

Dermatology Roundup: National Eczema Association Aims to Define “Flare”

By Matt Breeman Atopic Dermatitis, Dermatology Roundup, JDD Highlights, JDD in the Media, The Latest

By Allison Sit A National Eczema Association (NEA) study published in JAMA Dermatology identified patient-reported attributes associated with a “flare” of atopic dermatitis. The study sought to develop a clearer…

Sep 19

Love8

JDD in the News: Benefits of Long-Term Ixekizumab in Psoriasis; Secukinumab in Psoriasis Patients with Skin of Color

By Matt Breeman Acne, Atopic Dermatitis, Featured Articles, JDD Highlights, JDD in the Media, Psoriasis, Skin of Color, The Latest

by Allison Sit Healio wrote about two JDD studies on psoriasis treatments including one on the benefits of long-term ixekizumab. The study, “Benefits Over Five Years of Ixekizumab Treatment in…

Aug 19

Love8

JDD in the News: Racial and Ethnic Minority Underrepresentation in Vitiligo Clinical Trials; Combination Cream for Melasma

By Matt Breeman Atopic Dermatitis, Featured Articles, JDD Highlights, JDD in the Media, Melasma, Skin Cancer, Skin of Color, The Latest

by Allison Sit Managed Healthcare Executive and Healio both wrote about a JDD study on the underrepresentation of racial and ethnic minority groups in vitiligo research. The study, “Racial and…

Apr 16

Love8

JDD in the News: Efficacy and Tolerability of Stabilized, Bioactive Retinol

By Matt Breeman Atopic Dermatitis, Featured Articles, JDD Highlights, JDD in the Media, The Latest

by Allison Sit Dermatology Times, HAPPI, Healio and HealthDay all wrote about an April article in the Journal of Drugs in Dermatology that was one of one of the largest,…

Mar 26

Love7

JDD in the News: Cysteamine Isobionic-Amide Complex for Melasma

By Matt Breeman Atopic Dermatitis, Featured Articles, JDD Highlights, JDD in the Media, Melasma, The Latest

by Allison Sit Dermatology Advisor, Dermatology Times and Healio all covered recent articles in the Journal of Drugs in Dermatology. One study, “Cysteamine Isobionic-Amide Complex Versus Kligman’s Formula for the…

Jan 04

Love34

Prevention is the Best Medicine: ADing up the Data

By Krista Reznik Atopic Dermatitis, CME Activities, Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights No Comments

iTunes TuneIn Spotify Dr. Candrice Heath, Dr. Jonathan O’B. Hourihane & Dr. Adam Friedman Continue to CME Activity Atopic Dermatitis (AD) is the second most common chronic inflammatory (coming for…

NextPrevious »

© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

Atopic Dermatitis

Dupilumab Treatment Improves Lichenification in Atopic Dermatitis in Different Age and Racial Groups

Dermatology Roundup: Medicare Fee Schedule to Cut Physician Pay; Telemedicine Tool Found Accurate in Melanoma Diagnosis

A Review of the Vitiligo Literature to Standardize Expression of Disease Severity

Efficacy and Tolerance of a Polymeric Surfactant Technology-Based Cleanser for Clinically Diagnosed Sensitive Skin

Breaking New Ground in Atopic Dermatitis Treatment: Dr. Linda Stein Gold Discusses the “Level Up” Study

Dermatology Roundup: Semaglutide for HS, Acne Laser Receives FDA Clearance

Dermatology Roundup: National Eczema Association Aims to Define “Flare”

JDD in the News: Benefits of Long-Term Ixekizumab in Psoriasis; Secukinumab in Psoriasis Patients with Skin of Color

JDD in the News: Racial and Ethnic Minority Underrepresentation in Vitiligo Clinical Trials; Combination Cream for Melasma

JDD in the News: Efficacy and Tolerability of Stabilized, Bioactive Retinol

JDD in the News: Cysteamine Isobionic-Amide Complex for Melasma

Prevention is the Best Medicine: ADing up the Data

Advertisement

Dermatology Topics

Advertisement

Top News Stories

News Topics

Journal of Drugs in Dermatology

Search